Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Adenocarcinoma Gastric × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 114 Breast Neoplasms 101 Neoplasms 82 Neoplasm Metastasis 75 Leukemia, Myeloid, Acute 71 Colorectal Neoplasms 64 Melanoma 63 Prostatic Neoplasms 62 Lung Neoplasms 50 Ovarian Neoplasms 49 Multiple Myeloma 45 Pancreatic Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 40 Recurrence 39 Triple Negative Breast Neoplasms 37 Carcinoma, Renal Cell 34 Carcinoma, Hepatocellular 33 Myelodysplastic Syndromes 32 Lymphoma, Non-Hodgkin 32 Brain Neoplasms 32 Endometrial Neoplasms 30 Lymphoma 28 Uterine Cervical Neoplasms 27 Stomach Neoplasms 27 Leukemia 27 Glioblastoma 27 Cholangiocarcinoma 27 Head and Neck Neoplasms 24 Leukemia, Lymphocytic, Chronic, B-Cell 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22

Interventions

tusamitamab ravtansine 1 Ramucirumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05071053 2025-08-22

CARMEN-GC01

Sanofi

Phase 2 Terminated

35 enrolled 14 charts

Gastrointestinal

Adenocarcinoma Gastric

Data powered by HemOnc (CC BY 4.0) Colophon ⚡